Lifestance Health Group (LFST) investor relations material

Industry trends and market dynamics

• Outpatient mental health is a $50 billion and growing market, driven by rising demand, increased diagnosis, and reduced social stigma.

• Migration from cash pay to insurance is accelerating due to affordability challenges and pressure on payers to improve network adequacy.

• The industry remains highly fragmented and is in the early stages of consolidation, with most practitioners in small or solo practices.

Unique positioning and business model

• Operates at scale with over 8,300 clinicians, 9 million annual visits, and presence in 33 states.

• Hybrid care model offers both virtual and in-person services, with over 575 centers providing a competitive edge.

• Broad service range includes therapy, psychiatry, neuropsych testing, and new specialty lines like SPRAVATO and TMS for treatment-resistant depression.

• Focuses on commercial insurance patients, which account for 90% of revenue, with low patient acquisition costs below 2% of revenue.

Performance, outcomes, and financial outlook

• Patient satisfaction averages 4.7 out of 5 stars across centers, supporting strong referral growth.

• Outcomes tracking shows about 75% of patients with depression or anxiety achieve clinically significant improvement.

• Revenue guidance for 2026 implies a 16% three-year CAGR, with adjusted EBITDA margins improving from 5.5% in 2023 to over 12.5% in 2024.

• Achieved positive free cash flow for three consecutive years and positive net income for two years.

• Guidance targets mid-teens EBITDA margins by 2028, with a long-term path to 15%-20% margins.